




Suppl. Figure 1: Anti-tumor effect of bortezomib in BON cells involves induction of cell cycle 
arrest and apoptosis: A) Human tumor colony assay (HTCA) demonstrated a reduced clonogenic 
potential of BON cells 9 days after bortezomib treatment (representative data of three independent 
experiments with n=3). Captions: *p<0.05 (Kruskal-Wallis test with Dunn's multiple comparisons 
testing). Whereas B) control and C) cisplatin (10 µM) treated cells retained the characteristic 
morphology of BON cells in 2D culture, cells treated with D) bortezomib (25 nM) or E) bortezomib (25 
nM) and cisplatin (10 µM) exhibited strong morphological changes and occurrence of anoikis as early 
as 24 h after treatment start. We therefore chose a short incubation time and a low dose (compared to 
the calculated IC50) for the following experiments. F+G) GEP-NEN cells were treated with 50 nM 
bortezomib, 10 µM cisplatin or both versus saline for 24 h and analyzed by phospho-histone H3 / 
propidium iodide flow cytometry. In KRJ-I cells cisplatin induced cell cycle arrest in S- and G2-phase. 
Bortezomib induced G2 arrest and a higher percentage of dead cells, indicated by an increased sub-G1 
phase. The combinatory treatment showed a significant rise in the sub-G1 cell population (p=0.0429; 
Kruskal-Wallis test with Dunn’s multiple comparisons test). KRJ-I cells were analyzed after 16 h and 
20 h of analogous treatment by JC-1 staining of depolarized mitochondrial membranes as flow 
cytometry marker for early apoptosis induction. A strong apoptosis induction (p-values calculated 
versus saline controls) was shown after bortezomib and combinatory treatment (ANOVA with Dunnett’s 
multiple comparisons test). BON cells exhibited an increased S-phase after cisplatin and G2/M arrest 
after bortezomib treatment along with a reduced G1 population. The combinatory treatment showed a 
marginally enhanced induction of cell death resulting in a sub-G1 peak (Kruskal-Wallis test with Dunn’s 
multiple comparisons test). This induced cell death was in part verified as apoptosis and reached 
significance (versus saline) for bortezomib monotherapy and combination after 20 h (ANOVA with 
Dunnett’s multiple comparisons test). Representative data of n=3 independent experiments; Captions: 




Suppl. Figure 2: Western blot analyses of bortezomib-induced effects in four different GEP-NEN 
cell lines:  Cell lines were treated for 48 h with respective doses of bortezomib alone (BON: 25 nM, 
KRJ-I: 20 nM, LCC-18: 500 nM, QGP-1: 5 µM) or combined with cisplatin (10 µM). A) Combined 
treatment induced cellular ER stress indicated by CK2-alpha upregulation and PI3K pathway activation.  
B) Validation of BON cell-obtained data in three other NEN cell lines: cell cycle, apoptosis and DNA-
damage associated protein expression upon bortezomib treatment of KRJ-I cells and C) after combined 
treatment. D) Cell cycle, apoptosis and DNA-damage associated protein expression upon bortezomib 




Suppl. Figure 3: Radiosensitizing effect of bortezomib: KRJ-I and BON cells were irradiated with 0, 
5 or 10 Gy using a caesium-137 source and treated with increasing concentrations of bortezomib for 48 
h. Metabolic activity was measured by AlamarBlues to estimate cell count. A+B) Addition of 
bortezomib induced enhanced anti-proliferative effects (p<0.0001) in both cell lines (ANOVA; Holm-
Sidak’s test for multiple testing), which were quantitated as synergistic in doses of bortezomib <20 nM 
in KRJ-I using the method of Chou and Talalay. C+D) Analysis of cells following radiation (IR), 
bortezomib (Bor), control (ctrl.) and combined (Bor+IR) treatment. Cells were treated with 10 Gy 
radiation and 5 nM bortezomib for 48 h. Respective controls were no radiation or PBS. Western Blot 
demonstrated the downregulation of FOXM1 and SKP2, as well as induction of apoptosis (indicated by 





Suppl. Figure 4: Western blot raw data of chicken CAM xenografted tumors treated with saline, 
PRRT, bortezomib and combined therapy. Eggs were treated with ~20 MBq 177-Lu-DOTATOC 
(PRRT) i.v. with and without 25 nM bortezomib. Tumor plaques were explanted 6 days after treatment. 
Three independent experiments of >4 experiments are shown. Gel 1-4 were loaded with identical 
samples and re-probed with the specified antibodies. A) Western blot raw data of protein expression in 
chicken CAM xenografted tumors: three samples per treatment group. B) Protein load after western 
blotting was determined by ponceau S staining to evaluate total protein for normalization purposes.  
Arrows indicate positions where one lane was excluded from the analyses due to poor total protein 
abundance of the (predominantly necrotic) tissue lysate. 
 
 
Suppl. Figure 5: Role of FOXM1 upon bortezomib treatment: Cell lines were treated with their 
effective doses of bortezomib (KRJ-I: 20 nM, LCC-18: 500 nM, BON: 25 nM, QGP-1: 5 µM) for 48 h 
in vitro. A) Western blot detection of FOXM1 show a reduced protein abundance after bortezomib 
treatment versus control. B) BON cells have further been analyzed by qPCR, demonstrating that also 
the FOXM1 mRNA was reduced under bortezomib treatment. This indicates a transcriptional regulation 
of FOXM1 by bortezomib rather than contribution of posttranscriptional mechanisms (Mann-Whitney 
test, p=0.0238). Captions: *p<0.05. C) BON cells were transfected with 40 nM FOMX1 siRNA versus 
negative control siRNA for 72 h. Knockdown efficacy was determined by qPCR (refer to e). 
Alternatively, BON cells were treated with 25 nM bortezomib versus control for 24 h. Triplicates for 
every group were analyzed using the nCounter® array and differentially expressed genes (filtered by 
fold-change ≥1.5) were identified. The expression of 39 genes was altered in the same direction by both 
FOXM1 knockdown and bortezomib. D) According to the PANTHER overrepresentation analysis, 
genes of cell cycle proteins and several apoptosis-associated pathways were overrepresented within 
these 39 analogously affected genes. E) RT-qPCR based determination of knockdown efficacy against 
FOXM1 and the FOXM1 isoform B. Median data of three independent experiments is shown. Each point 
itself represents the median of five technical replicates that are not shown in detail.  
Captions: *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001; *****p<0.00001. Corresponding gene 




Suppl. Figure 6: Kaplan-Maier survival analysis of cumulative time to endpoint (volume=1400 
mm3). Since mice were euthanized at a defined end point and did not die spontaneously, the survival 
was defined as time to endpoint. The time to endpoint was significantly increased in the Lu-177-
DOTATOC and the combined treatment group versus saline according to a Log-rank (Mantel-Cox) test 
(p=0.0079). Combination therapy increased the median time to endpoint from 63.5 days in the 
bortezomib to 77.5 days in the combined group (p=0.0169). However, Lu-177-DOTATOC 





Suppl. Figure 7: Raw data of immunohistochemically stained mouse xenograft tumor specimens: 
Mouse xenograft tumors were explanted, paraffin embedded and specimens of the tumor rim area were 
stained against the proliferation marker anti-Ki-67, the hypoxia marker HIF1-alpha, the DNA damage 
marker anti-53BP1 and the apoptosis marker cleaved PARP. Captions: cPARP=cleaved Poly- (ADP-
ribose)- polymerase. 3/4 specimens are shown. Light microscopy: original x100 magnification, scale 
bar indicates 100 µm.  
SUPPLEMENTARY TABLES: 
 












limit p-value FDR pathway 
ABL1 -0,1557 -0,2562 -0,0553 1,89E-02 6,26E-01 RAS, CC 
ALK -1,1623 -1,9890 -0,3356 2,83E-02 7,88E-01  
ALKBH2 0,3965 0,1160 0,6770 2,77E-02 7,86E-01 DNARepair 
ALKBH3 -0,1642 -0,2905 -0,0379 3,82E-02 9,37E-01 DNARepair 
ARID1A -0,4049 -0,6050 -0,2048 5,42E-03 3,13E-01 ChromMod 
ARNT2 -0,4080 -0,5429 -0,2732 5,82E-04 7,35E-02 TXmisReg 
ATRX -0,3186 -0,4877 -0,1495 7,73E-03 3,61E-01  
BID 0,4140 0,1932 0,6348 7,91E-03 3,65E-01 Apop 
BMP4 0,3652 0,2423 0,4880 6,46E-04 7,60E-02 HH, TGFB 
BMP7 -0,4353 -0,6170 -0,2536 2,22E-03 1,75E-01 TGFB 
BMP8A 0,6066 0,3084 0,9048 5,28E-03 3,10E-01 TGFB 
BMPR1B -0,3590 -0,4757 -0,2423 5,27E-04 7,26E-02 TGFB 
BNIP3 0,1887 0,0750 0,3025 1,40E-02 5,20E-01 ChromMod 
BRCA1 0,4938 0,2614 0,7262 4,22E-03 2,72E-01 DNARepair, PI3K 
BRCA2 0,2619 0,0776 0,4462 2,71E-02 7,77E-01 DNARepair 
BRIP1 0,2572 0,0721 0,4423 2,96E-02 7,96E-01 DNARepair 
C19orf40 0,4330 0,1356 0,7304 2,46E-02 7,35E-01 DNARepair 
CACNA1C -0,9017 -1,4513 -0,3521 1,47E-02 5,29E-01 MAPK 
CACNA1H -0,6506 -0,8638 -0,4373 5,53E-04 7,26E-02 MAPK 
CACNA2D1 -0,5224 -0,6725 -0,3722 2,49E-04 4,72E-02 MAPK 
CACNA2D2 -0,5838 -0,8792 -0,2883 6,11E-03 3,35E-01 MAPK 
CACNB2 -0,4375 -0,7676 -0,1073 3,56E-02 8,99E-01 MAPK 
CARD11 -1,4065 -1,8095 -1,0035 2,44E-04 4,72E-02  
CASP7 0,1719 0,0488 0,2950 2,91E-02 7,93E-01 Apop 
CASP9 0,4542 0,0855 0,8229 4,65E-02 1,00E+00 PI3K, Apop 
CBL -0,4682 -0,8480 -0,0883 4,64E-02 1,00E+00 STAT 
CCNA2 0,2112 0,0670 0,3554 2,40E-02 7,35E-01 CC 
CCNB1 -0,2276 -0,3697 -0,0855 1,64E-02 5,70E-01 CC 
CCNE1 0,5971 0,3730 0,8213 1,22E-03 1,16E-01 PI3K, CC 
CCNE2 0,7290 0,5643 0,8937 5,42E-05 1,95E-02 PI3K, CC 
CDC25A 0,6863 0,4798 0,8928 3,30E-04 5,79E-02 CC 
CDC25B 0,1945 0,0839 0,3052 1,07E-02 4,42E-01 MAPK, CC 
CDC25C -0,5170 -0,7974 -0,2366 8,58E-03 3,77E-01 CC 
CDC6 0,4345 0,2735 0,5954 1,13E-03 1,11E-01 CC 
CDC7 0,1784 0,0371 0,3196 4,26E-02 1,00E+00 CC 
CDH1 -0,2515 -0,3834 -0,1195 7,32E-03 3,55E-01  
CDKN1A 1,2748 1,0970 1,4527 2,19E-06 2,49E-03 TXmisReg, PI3K, 
CC 
CEBPA 0,8934 0,2456 1,5413 3,05E-02 8,13E-01 TXmisReg 
CHEK1 0,2561 0,1214 0,3907 7,38E-03 3,55E-01 CC 
COL27A1 -0,9882 -1,2013 -0,7751 4,00E-05 1,95E-02 PI3K 
CREB3L4 -0,3792 -0,6751 -0,0833 4,03E-02 9,62E-01 PI3K 
CUL1 0,1332 0,0254 0,2410 4,59E-02 1,00E+00 Wnt, TGFB, CC 
CXXC4 -0,8076 -1,3992 -0,2160 3,17E-02 8,35E-01 Wnt 
DDB2 0,2720 0,2053 0,3387 9,18E-05 2,61E-02 DNARepair 
DDIT3 -0,3751 -0,5862 -0,1639 1,02E-02 4,32E-01 TXmisReg, 
MAPK 
DKK1 -0,4734 -0,7443 -0,2025 1,11E-02 4,49E-01 Wnt 
DKK4 0,6348 0,2654 1,0042 1,19E-02 4,69E-01 Wnt 
DLL1 -0,3344 -0,5661 -0,1028 2,54E-02 7,46E-01 Notch 
DLL3 -0,3865 -0,5692 -0,2039 4,31E-03 2,72E-01 Notch 
DLL4 -0,4829 -0,7430 -0,2228 8,30E-03 3,77E-01 Notch 
DUSP5 -0,4323 -0,6160 -0,2485 2,45E-03 1,82E-01 MAPK 
DUSP6 -0,4258 -0,6763 -0,1753 1,26E-02 4,82E-01 TXmisReg, 
MAPK 
EFNA5 -0,5419 -0,7946 -0,2892 4,02E-03 2,69E-01 PI3K, RAS 
EGFR -0,2313 -0,4166 -0,0459 4,44E-02 1,00E+00 MAPK, PI3K, 
RAS 
EPOR -0,5802 -0,8952 -0,2653 8,62E-03 3,77E-01 STAT, PI3K 
ETV1 -0,4662 -0,6115 -0,3208 4,10E-04 6,60E-02 TXmisReg 
EZH2 0,2823 0,0812 0,4833 2,84E-02 7,88E-01  
FANCA 0,2219 0,0789 0,3649 1,88E-02 6,26E-01 DNARepair 
FANCB 0,2866 0,0681 0,5050 3,70E-02 9,20E-01 DNARepair 
FANCF -0,3887 -0,6550 -0,1223 2,43E-02 7,35E-01 DNARepair 
FAS 0,8078 0,2996 1,3161 1,69E-02 5,78E-01 MAPK, Apop 
FEN1 0,4841 0,2756 0,6926 2,63E-03 1,91E-01 DNARepair 
FGF11 -0,4957 -0,6860 -0,3055 1,39E-03 1,25E-01 MAPK, PI3K, 
RAS 
FGF12 -0,4392 -0,6094 -0,2690 1,47E-03 1,28E-01 MAPK, PI3K, 
RAS 
FGF14 -0,7653 -0,8350 -0,6955 1,19E-07 4,05E-04 MAPK, PI3K, 
RAS 
FGFR1 -0,2498 -0,4015 -0,0980 1,45E-02 5,27E-01 MAPK, PI3K, 
RAS 
FGFR3 0,5514 0,3679 0,7350 6,07E-04 7,39E-02 MAPK, PI3K, 
RAS 
FLNC -0,8631 -1,5720 -0,1542 4,84E-02 1,00E+00 MAPK 
FUBP1 -0,3625 -0,5684 -0,1567 1,07E-02 4,42E-01  
FUT8 -0,5141 -0,9000 -0,1282 3,49E-02 8,88E-01 TXmisReg 
GADD45G -0,8854 -1,0810 -0,6898 4,68E-05 1,95E-02 MAPK, CC 
GNAQ -0,2308 -0,3508 -0,1107 7,02E-03 3,52E-01  
GNG12 -0,5537 -0,7125 -0,3949 2,45E-04 4,72E-02 MAPK, PI3K, 
RAS 
GSK3B -0,2320 -0,3239 -0,1401 1,66E-03 1,35E-01 Wnt, HH, PI3K, 
CC 
HDAC10 -0,6103 -0,9132 -0,3074 5,54E-03 3,15E-01 ChromMod 
HDAC4 -0,7292 -1,1514 -0,3070 1,17E-02 4,65E-01 ChromMod 
HDAC6 -0,3654 -0,6195 -0,1114 2,58E-02 7,46E-01 ChromMod 
HELLS 0,2754 0,0629 0,4879 3,87E-02 9,37E-01 ChromMod 
HGF -0,5717 -0,9692 -0,1743 2,58E-02 7,46E-01 PI3K, RAS 
HIST1H3G -0,4718 -0,7970 -0,1465 2,49E-02 7,40E-01 TXmisReg 
HIST1H3H -0,9513 -1,2992 -0,6034 1,05E-03 1,06E-01 TXmisReg 
HMGA2 -0,4619 -0,7449 -0,1789 1,51E-02 5,31E-01 TXmisReg 
HNF1A -0,8291 -1,4885 -0,1696 4,32E-02 1,00E+00  
HSP90B1 -0,4192 -0,5282 -0,3101 1,34E-04 3,51E-02 PI3K 
HSPA2 -0,2078 -0,3682 -0,0474 3,87E-02 9,37E-01 MAPK 
ID2 -0,3185 -0,5249 -0,1121 1,93E-02 6,31E-01 TXmisReg, TGFB 
IGF1R -0,4040 -0,6126 -0,1954 6,75E-03 3,45E-01 TXmisReg, PI3K, 
RAS 
INHBB -0,3738 -0,5988 -0,1488 1,39E-02 5,20E-01 TGFB 
JAG1 -0,2598 -0,3915 -0,1280 6,18E-03 3,35E-01 Notch 
KDM5C -0,2776 -0,4454 -0,1097 1,42E-02 5,22E-01  
KMT2C -0,2337 -0,4080 -0,0594 3,40E-02 8,79E-01  
LAMA5 -0,5816 -0,9717 -0,1915 2,23E-02 7,04E-01 PI3K 
LAMC2 -0,2888 -0,4843 -0,0933 2,32E-02 7,18E-01 PI3K 
LAT -1,0356 -1,5789 -0,4924 7,30E-03 3,55E-01 RAS 
LEPR -0,8405 -1,1676 -0,5134 1,50E-03 1,28E-01 STAT 
LFNG -0,8445 -1,0766 -0,6124 1,88E-04 4,59E-02 Notch 
LIFR -0,6193 -0,9782 -0,2604 1,17E-02 4,65E-01 STAT 
LTBP1 -0,5514 -0,8218 -0,2810 5,21E-03 3,10E-01 TGFB 
MAD2L2 0,3689 0,2913 0,4464 3,40E-05 1,95E-02 DNARepair, CC 
MAP2K6 -0,4078 -0,5531 -0,2626 9,04E-04 9,64E-02 MAPK 
MAPK8 -0,2056 -0,2678 -0,1435 3,39E-04 5,79E-02 Wnt, MAPK, RAS 
MAPT -1,0542 -1,4114 -0,6969 6,75E-04 7,67E-02 MAPK 
MDC1 -0,3587 -0,6216 -0,0958 3,18E-02 8,35E-01 DNARepair 
MET 0,1854 0,0828 0,2880 9,44E-03 4,08E-01 TXmisReg, PI3K, 
RAS 
MLLT3 -0,2374 -0,3279 -0,1469 1,34E-03 1,23E-01 TXmisReg 
MLLT4 -0,4147 -0,6688 -0,1607 1,51E-02 5,31E-01 RAS 
MSH2 0,2387 0,1319 0,3455 3,23E-03 2,20E-01  
MYB 0,2744 0,0799 0,4688 2,79E-02 7,86E-01 PI3K 
NASP 0,3552 0,1246 0,5859 1,94E-02 6,31E-01 ChromMod 
NFKBIA 0,3243 0,1885 0,4602 2,26E-03 1,75E-01 Apop 
NKD1 -0,5607 -0,7819 -0,3394 1,62E-03 1,35E-01 Wnt 
NOTCH1 1,0325 0,3372 1,7277 2,26E-02 7,09E-01 Notch 
NOTCH2 -0,5027 -0,8327 -0,1728 2,03E-02 6,54E-01 Notch 
NRAS -0,2296 -0,3678 -0,0915 1,39E-02 5,20E-01 MAPK, PI3K, 
RAS 
NSD1 -0,3992 -0,7025 -0,0959 3,65E-02 9,15E-01 ChromMod 
NUMBL 0,4564 0,2150 0,6978 7,59E-03 3,60E-01 Notch 
PBX1 -0,6909 -0,9148 -0,4669 5,18E-04 7,26E-02 TXmisReg 
PDGFD -0,4389 -0,5964 -0,2813 9,46E-04 9,78E-02 PI3K, RAS 
PIK3R1 -0,2889 -0,4750 -0,1028 1,88E-02 6,26E-01 STAT, PI3K, 
RAS, Apop 
PLA2G4C -0,3983 -0,7170 -0,0796 4,41E-02 1,00E+00 MAPK, RAS 
PLCB1 -1,3180 -1,4962 -1,1399 1,77E-06 2,49E-03 Wnt 
PLCG2 -0,6667 -0,9626 -0,3708 3,09E-03 2,15E-01 RAS 
POLD4 -0,3172 -0,4546 -0,1797 2,72E-03 1,94E-01 DNARepair 
POLE2 0,4328 0,1126 0,7529 3,30E-02 8,59E-01 DNARepair 
POLR2D 0,2532 0,1106 0,3957 1,03E-02 4,32E-01 DNARepair 
PRKAR1B -0,2775 -0,4082 -0,1468 4,24E-03 2,72E-01 Apop 
PRKCG -0,6555 -0,9898 -0,3212 6,35E-03 3,38E-01 Wnt, MAPK, RAS 
RAD21 -0,1477 -0,2213 -0,0740 5,68E-03 3,18E-01 CC 
RAD51 0,4556 0,3065 0,6048 5,50E-04 7,26E-02 DNARepair 
RASGRF2 -0,4793 -0,8553 -0,1034 4,11E-02 9,73E-01 MAPK, RAS 
RFC3 0,4220 0,3281 0,5160 4,91E-05 1,95E-02 DNARepair 
RFC4 0,0951 0,0172 0,1730 4,80E-02 1,00E+00 DNARepair 
SHC2 -0,4916 -0,8278 -0,1554 2,41E-02 7,35E-01 RAS 
SKP2 -0,2696 -0,3311 -0,2082 5,71E-05 1,95E-02 CC 
SMC3 0,1585 0,0449 0,2720 2,91E-02 7,93E-01 CC 
SOS2 -0,4143 -0,5617 -0,2670 8,96E-04 9,64E-02 MAPK, STAT, 
PI3K, RAS 
SPOP -0,7133 -1,2651 -0,1614 3,90E-02 9,38E-01  
SPRY1 -0,3783 -0,5642 -0,1923 5,28E-03 3,10E-01 STAT 
SPRY2 -0,6930 -0,9862 -0,3998 2,39E-03 1,81E-01 STAT 
SPRY4 -0,8303 -0,9832 -0,6774 1,42E-05 1,21E-02 STAT 
SUV39H2 0,3127 0,0784 0,5471 3,46E-02 8,88E-01 ChromMod 
TGFB3 -0,6653 -0,8196 -0,5110 6,41E-05 1,99E-02 TGFB, MAPK, 
CC 
TIAM1 -0,5262 -0,8355 -0,2169 1,25E-02 4,82E-01 RAS 
TLX1 0,3876 0,1095 0,6658 2,93E-02 7,93E-01 TXmisReg 
TNFSF10 -0,4301 -0,6624 -0,1977 8,42E-03 3,77E-01 Apop 
TNR -1,2474 -1,6056 -0,8892 2,47E-04 4,72E-02 PI3K 
TSC1 -0,3084 -0,5014 -0,1154 1,66E-02 5,71E-01 PI3K 
UBE2T 0,3179 0,0740 0,5618 3,78E-02 9,35E-01 DNARepair 
WHSC1 -0,1499 -0,2231 -0,0766 5,12E-03 3,10E-01 TXmisReg 
WHSC1L1 -0,0795 -0,1319 -0,0270 2,09E-02 6,65E-01 ChromMod 
WNT3 0,7061 0,3416 1,0707 6,75E-03 3,45E-01 Wnt, HH 
WNT7A -0,8165 -1,4859 -0,1472 4,81E-02 1,00E+00 Wnt, HH 
XRCC4 -0,7366 -0,9677 -0,5055 4,26E-04 6,60E-02 DNARepair 




Suppl. table 2: differentially expressed genes after 24 h of 25 nM bortezomib treatment of BON cells 











limit p-value FDR pathway 
ABL1 0,3366 0,2243 0,4489 6,15E-04 1,42E-02 RAS, CC 
AKT1 -0,6591 -0,8659 -0,4524 4,24E-04 1,07E-02 MAPK, STAT, 
PI3K, RAS, 
Apop 
AKT2 -0,6014 -0,8642 -0,3386 2,85E-03 4,61E-02 MAPK, STAT, 
PI3K, RAS, 
Apop 
ALKBH3 0,5896 0,4484 0,7308 7,88E-05 2,93E-03 DNARepair 
AMER1 -0,7898 -1,0707 -0,5089 8,97E-04 1,84E-02  
ARID1A -0,5421 -0,7658 -0,3183 2,09E-03 3,52E-02 ChromMod 
ARNT2 -0,8587 -1,0095 -0,7080 1,03E-05 5,96E-04 TXmisReg 
ATR -0,8217 -1,1364 -0,5070 1,37E-03 2,54E-02 CC 
B2M -0,9285 -1,0701 -0,7870 3,99E-06 2,83E-04  
BAIAP3 -1,3912 -1,5774 -1,2051 1,65E-06 1,64E-04 TXmisReg 
BAX -0,6289 -0,7962 -0,4616 1,53E-04 4,76E-03 Apop 
BCL2 -1,2656 -1,6325 -0,8987 2,62E-04 7,52E-03 PI3K, Apop 
BCOR -1,3179 -1,5292 -1,1065 5,62E-06 3,49E-04  
BID 0,6998 0,4530 0,9467 8,54E-04 1,78E-02 Apop 
BMP6 1,4292 0,8547 2,0036 1,80E-03 3,09E-02 TGFB 
BMP7 -1,5367 -1,7399 -1,3335 1,52E-06 1,64E-04 TGFB 
BMPR1B -0,4257 -0,5562 -0,2952 3,69E-04 9,69E-03 TGFB 
BNIP3 0,7793 0,6521 0,9065 6,32E-06 3,73E-04 ChromMod 
BRCA2 -0,5108 -0,7168 -0,3047 1,84E-03 3,13E-02 DNARepair 
BRIP1 -0,6544 -0,8613 -0,4474 4,47E-04 1,10E-02 DNARepair 
CACNA2D1 -1,1894 -1,3573 -1,0215 2,37E-06 2,08E-04 MAPK 
CACNB2 -1,0934 -1,4625 -0,7242 6,60E-04 1,49E-02 MAPK 
CAPN2 1,1210 1,0385 1,2035 2,70E-08 1,74E-05 Apop 
CASP3 -0,6546 -0,8157 -0,4935 9,38E-05 3,30E-03 MAPK, Apop 
CASP7 0,6847 0,5471 0,8224 2,53E-05 1,16E-03 Apop 
CASP8 0,5109 0,3014 0,7204 2,01E-03 3,42E-02 Apop 
CCNA2 -1,2025 -1,3637 -1,0413 1,67E-06 1,64E-04 CC 
CCNB1 -0,4559 -0,6148 -0,2971 7,95E-04 1,72E-02 CC 
CCND1 -1,8714 -2,1630 -1,5799 4,63E-06 3,10E-04 Wnt, STAT, 
PI3K, CC 
CCNE1 -2,1695 -2,4202 -1,9189 6,05E-07 9,50E-05 PI3K, CC 
CCNE2 -1,6783 -1,8624 -1,4941 4,25E-07 8,06E-05 PI3K, CC 
CDC14A -0,8511 -1,0427 -0,6595 5,30E-05 2,10E-03 CC 
CDC25A -0,8937 -1,1246 -0,6628 1,28E-04 4,11E-03 CC 
CDC25B -0,8173 -0,9410 -0,6936 3,81E-06 2,82E-04 MAPK, CC 
CDC6 -0,5857 -0,7656 -0,4058 3,74E-04 9,75E-03 CC 
CDC7 -1,2969 -1,4549 -1,1390 8,70E-07 1,23E-04 CC 
CDH1 -0,4427 -0,5903 -0,2951 6,12E-04 1,42E-02  
CDK4 -0,8264 -0,9800 -0,6728 1,51E-05 7,67E-04 PI3K, CC 
CDK6 -0,5940 -0,8092 -0,3787 1,00E-03 2,00E-02 PI3K, CC 
CDKN1A 1,2400 1,0411 1,4388 5,62E-06 3,49E-04 TXmisReg, 
PI3K, CC 
CDKN2D -0,7955 -1,0911 -0,4998 1,16E-03 2,23E-02 CC 
CEBPA 2,2668 1,5425 2,9911 4,75E-04 1,17E-02 TXmisReg 
CHEK2 -0,7792 -0,9532 -0,6052 5,02E-05 2,01E-03 CC 
CHUK -0,4777 -0,6444 -0,3110 8,03E-04 1,72E-02 MAPK, PI3K, 
RAS, Apop 
CREB3L1 -0,8368 -1,0037 -0,6700 2,39E-05 1,12E-03 PI3K 
CUL1 0,2741 0,1535 0,3946 2,95E-03 4,72E-02 Wnt, TGFB, CC 
CXXC4 -1,5557 -2,2171 -0,8943 2,46E-03 4,03E-02 Wnt 
CYLD 0,7492 0,5581 0,9403 1,18E-04 3,98E-03  
DDB2 -0,7378 -0,8124 -0,6632 2,42E-07 6,35E-05 DNARepair 
DDIT3 1,5447 1,3087 1,7808 4,07E-06 2,83E-04 TXmisReg, 
MAPK 
DLL1 -2,1333 -2,3923 -1,8743 8,51E-07 1,23E-04 Notch 
DLL3 -1,7651 -1,9693 -1,5608 6,12E-07 9,50E-05 Notch 
DLL4 -1,8699 -2,1607 -1,5791 4,57E-06 3,10E-04 Notch 
DNMT1 -0,4372 -0,5895 -0,2849 7,94E-04 1,72E-02  
DNMT3A -0,4498 -0,6234 -0,2763 1,43E-03 2,62E-02  
DUSP4 -0,8571 -1,0377 -0,6764 3,44E-05 1,45E-03 MAPK 
DUSP5 0,6059 0,4005 0,8114 6,77E-04 1,51E-02 MAPK 
DUSP6 -2,1433 -2,4234 -1,8632 1,41E-06 1,60E-04 TXmisReg, 
MAPK 
E2F1 -1,4315 -1,5713 -1,2916 1,91E-07 5,93E-05 CC 
E2F5 -1,7917 -1,9837 -1,5998 3,61E-07 7,71E-05 TGFB, CC 
EFNA5 -0,7824 -1,0649 -0,4998 9,79E-04 1,98E-02 PI3K, RAS 
ENDOG -1,8438 -2,1961 -1,4914 1,81E-05 8,95E-04 Apop 
EPOR -1,0915 -1,4436 -0,7393 5,03E-04 1,21E-02 STAT, PI3K 
ERCC2 -0,5733 -0,8260 -0,3205 2,99E-03 4,74E-02 DNARepair 
ETS2 -1,6853 -1,8216 -1,5490 5,19E-08 1,97E-05 RAS 
ETV1 -1,7784 -1,9410 -1,6159 1,21E-07 4,12E-05 TXmisReg 
ETV4 -0,7773 -1,0095 -0,5452 3,15E-04 8,46E-03 TXmisReg 
FANCA -0,8619 -1,0218 -0,7021 1,48E-05 7,67E-04 DNARepair 
FANCC -0,6863 -0,8866 -0,4860 2,73E-04 7,71E-03 DNARepair 
FANCL -0,8263 -1,1568 -0,4957 1,75E-03 3,05E-02 DNARepair 
FBXW7 -0,6781 -0,9783 -0,3779 3,05E-03 4,80E-02  
FEN1 -1,0517 -1,2848 -0,8186 4,78E-05 1,94E-03 DNARepair 
FGF11 -0,5135 -0,7263 -0,3008 2,13E-03 3,56E-02 MAPK, PI3K, 
RAS 
FGF14 -1,5055 -1,5835 -1,4275 2,34E-09 2,67E-06 MAPK, PI3K, 
RAS 
FGF9 0,9364 0,6966 1,1762 1,21E-04 4,00E-03 MAPK, PI3K, 
RAS 
FGFR3 -0,8419 -1,0471 -0,6367 8,82E-05 3,13E-03 MAPK, PI3K, 
RAS 
FLNA 1,2589 1,1022 1,4157 1,01E-06 1,23E-04 MAPK 
FLNC 1,7934 1,0008 2,5860 3,03E-03 4,78E-02 MAPK 
FN1 0,4402 0,2757 0,6046 1,19E-03 2,27E-02 PI3K 
FOSL1 2,4229 2,1215 2,7242 1,00E-06 1,23E-04 Wnt 
FZD10 -0,9869 -1,2775 -0,6962 2,89E-04 8,02E-03 Wnt 
FZD3 -0,6598 -0,9402 -0,3795 2,44E-03 4,03E-02 Wnt 
GADD45B 0,9785 0,6142 1,3429 1,17E-03 2,24E-02 MAPK, CC 
GATA2 -1,2123 -1,7156 -0,7090 2,15E-03 3,59E-02  
GNG12 -1,1866 -1,3642 -1,0091 3,52E-06 2,73E-04 MAPK, PI3K, 
RAS 
GNG4 -1,1454 -1,4793 -0,8114 2,72E-04 7,71E-03 PI3K, RAS 
GRB2 0,6103 0,4898 0,7309 2,25E-05 1,10E-03 MAPK, STAT, 
PI3K, RAS 
H2AFX -0,8751 -1,1496 -0,6006 4,25E-04 1,07E-02 DNARepair 
H3F3A -1,3733 -1,6261 -1,1206 1,41E-05 7,44E-04 TXmisReg 
H3F3C -0,9595 -1,1560 -0,7631 2,85E-05 1,30E-03 TXmisReg 
HDAC1 -0,7388 -0,8912 -0,5863 3,00E-05 1,33E-03 Notch, 
ChromMod, 
TXmisReg, CC 
HDAC2 -0,5119 -0,7021 -0,3216 1,16E-03 2,23E-02 Notch, 
ChromMod, 
TXmisReg, CC 
HELLS -0,8021 -1,0397 -0,5645 3,00E-04 8,18E-03 ChromMod 
HES1 -2,3624 -2,6929 -2,0319 2,23E-06 2,01E-04 Notch 
HHEX 0,7536 0,5615 0,9457 1,17E-04 3,98E-03 TXmisReg 
HIST1H3B -1,2289 -1,6789 -0,7788 1,06E-03 2,10E-02 TXmisReg 
HIST1H3G -1,6737 -2,0373 -1,3101 4,20E-05 1,73E-03 TXmisReg 
HIST1H3H -0,9114 -1,3004 -0,5224 2,51E-03 4,09E-02 TXmisReg 
HMGA2 -3,0097 -3,3262 -2,6933 3,17E-07 7,71E-05 TXmisReg 
HOXA10 -0,8548 -1,1332 -0,5764 5,32E-04 1,27E-02 TXmisReg 
HRAS -0,7561 -1,0229 -0,4893 8,55E-04 1,78E-02 MAPK, PI3K, 
RAS 
HSP90B1 0,6654 0,5434 0,7873 1,37E-05 7,43E-04 PI3K 
HSPA1A 6,2823 5,5134 7,0513 8,99E-07 1,23E-04 MAPK 
HSPA2 -0,4965 -0,6758 -0,3171 9,81E-04 1,98E-02 MAPK 
HSPB1 2,5675 1,9314 3,2036 9,78E-05 3,41E-03 MAPK 
ID1 -3,6501 -4,0387 -3,2614 3,46E-07 7,71E-05 TGFB 
ID2 -3,0798 -3,3106 -2,8491 3,05E-08 1,74E-05 TXmisReg, 
TGFB 
ID4 -1,6233 -1,8406 -1,4061 1,65E-06 1,64E-04 TGFB 
IDH2 -1,7407 -1,9404 -1,5409 5,79E-07 9,50E-05  
IGFBP3 0,6462 0,3946 0,8979 1,51E-03 2,72E-02 TXmisReg 
IKBKG 0,7964 0,5923 1,0005 1,21E-04 4,00E-03 MAPK, PI3K, 
RAS, Apop 
IL12A 1,1282 0,6822 1,5742 1,64E-03 2,90E-02 STAT 
IL12RB2 -0,6300 -0,8500 -0,4099 8,07E-04 1,72E-02 STAT 
IL1R2 -0,8068 -1,1608 -0,4529 2,91E-03 4,68E-02 TXmisReg, 
MAPK 
IL20RB 1,2389 0,6929 1,7850 2,98E-03 4,74E-02 STAT 
IL6R 0,7019 0,4670 0,9368 6,26E-04 1,42E-02 STAT, PI3K 
INHBB -1,7327 -1,9843 -1,4811 2,87E-06 2,34E-04 TGFB 
IRS1 -0,8036 -1,0853 -0,5220 8,22E-04 1,74E-02 PI3K 
ITGA3 -0,5896 -0,7512 -0,4280 1,85E-04 5,63E-03 PI3K 
ITGB8 -2,0583 -2,4307 -1,6858 1,26E-05 7,05E-04 PI3K 
JAG2 -1,0978 -1,3808 -0,8148 1,26E-04 4,09E-03 Notch 
KITLG -0,6441 -0,8968 -0,3913 1,57E-03 2,81E-02 PI3K, RAS 
KMT2C 0,5618 0,3669 0,7567 7,74E-04 1,70E-02  
KRAS 0,3098 0,2481 0,3714 2,36E-05 1,12E-03 MAPK, PI3K, 
RAS 
LAMB3 1,1657 1,0156 1,3158 1,27E-06 1,50E-04 PI3K 
LFNG -3,2693 -3,5288 -3,0098 4,55E-08 1,97E-05 Notch 
LIF -1,3323 -1,6544 -1,0102 8,37E-05 3,05E-03 STAT 
LIG4 -0,8566 -1,1094 -0,6037 2,93E-04 8,07E-03 DNARepair 
MAD2L2 -0,3714 -0,4581 -0,2846 6,71E-05 2,59E-03 DNARepair, CC 
MAP2K1 0,5927 0,5132 0,6721 1,68E-06 1,64E-04 MAPK, PI3K, 
RAS 
MAP2K2 0,6737 0,4485 0,8988 6,21E-04 1,42E-02 MAPK, PI3K, 
RAS 
MAP2K6 -0,9997 -1,1621 -0,8373 6,13E-06 3,73E-04 MAPK 
MAP3K14 1,1246 0,7391 1,5101 7,22E-04 1,60E-02 MAPK, Apop 
MAP3K5 -1,0524 -1,3704 -0,7344 3,38E-04 9,02E-03 MAPK 
MAPK3 -0,6705 -0,8603 -0,4807 2,26E-04 6,71E-03 TGFB, MAPK, 
PI3K, RAS 
MAPK8 -0,4408 -0,5103 -0,3713 5,01E-06 3,29E-04 Wnt, MAPK, 
RAS 
MAPT 0,9231 0,5237 1,3225 2,70E-03 4,39E-02 MAPK 
MCM4 -0,6520 -0,8921 -0,4120 1,10E-03 2,14E-02 CC 
MCM5 -0,7211 -0,9718 -0,4704 7,85E-04 1,72E-02 CC 
MCM7 -0,5832 -0,8082 -0,3581 1,43E-03 2,62E-02 CC 
MECOM -1,3960 -1,7220 -1,0699 6,71E-05 2,59E-03 MAPK 
MET 1,0025 0,8878 1,1171 5,66E-07 9,50E-05 TXmisReg, 
PI3K, RAS 
MLF1 -0,5015 -0,6301 -0,3729 1,22E-04 4,00E-03 TXmisReg 
MLLT3 -0,6653 -0,7665 -0,5641 3,94E-06 2,83E-04 TXmisReg 
MSH2 -0,3092 -0,4285 -0,1898 1,44E-03 2,62E-02  
MYB -2,7014 -2,9188 -2,4840 5,01E-08 1,97E-05 PI3K 





NFKB1 -1,2252 -1,5769 -0,8735 2,47E-04 7,20E-03 TXmisReg, 
MAPK, PI3K, 
RAS, Apop 
NFKBIA -0,4176 -0,5695 -0,2658 1,02E-03 2,02E-02 Apop 
NKD1 -0,6500 -0,8973 -0,4026 1,32E-03 2,48E-02 Wnt 
NOTCH1 2,3585 1,5812 3,1358 5,72E-04 1,35E-02 Notch 
NOTCH3 1,3095 0,9004 1,7187 4,15E-04 1,06E-02 Notch 
NPM2 -1,0013 -1,4249 -0,5777 2,39E-03 3,96E-02 ChromMod 
NTHL1 -0,7357 -1,0301 -0,4412 1,76E-03 3,05E-02 DNARepair 
NUMBL 1,4653 1,1954 1,7351 1,42E-05 7,44E-04 Notch 
PBRM1 -0,5134 -0,7137 -0,3131 1,52E-03 2,74E-02  
PBX1 -0,8061 -1,0565 -0,5558 4,00E-04 1,03E-02 TXmisReg 
PBX3 -0,7303 -0,9050 -0,5556 7,82E-05 2,93E-03 TXmisReg 
PDGFD -0,7036 -0,8798 -0,5275 1,05E-04 3,60E-03 PI3K, RAS 
PGF 2,1554 1,7744 2,5365 1,08E-05 6,14E-04 PI3K, RAS 
PIK3CB -0,6277 -0,8776 -0,3779 1,70E-03 2,99E-02 STAT, PI3K, 
RAS, Apop 
PIK3R1 -0,6156 -0,8236 -0,4075 6,65E-04 1,49E-02 STAT, PI3K, 
RAS, Apop 
PIK3R3 -0,4713 -0,6442 -0,2984 1,07E-03 2,10E-02 STAT, PI3K, 
RAS, Apop 
PLA2G4C 1,1272 0,7709 1,4836 4,45E-04 1,10E-02 MAPK, RAS 
POLD4 -0,5233 -0,6770 -0,3696 2,84E-04 7,95E-03 DNARepair 
POLE2 -0,8989 -1,2568 -0,5409 1,71E-03 2,99E-02 DNARepair 
POLR2D -0,7733 -0,9327 -0,6140 2,97E-05 1,33E-03 DNARepair 
POLR2H -1,0265 -1,2751 -0,7778 8,48E-05 3,05E-03 DNARepair 
PPP2CB 0,6087 0,4438 0,7736 1,72E-04 5,28E-03 TGFB, PI3K 
PPP2R2C 1,7855 1,4991 2,0719 5,63E-06 3,49E-04 PI3K 
PPP3CB -0,8778 -1,2076 -0,5480 1,23E-03 2,33E-02 Wnt, MAPK, 
Apop 
PRKACA -0,8361 -0,9573 -0,7149 2,84E-06 2,34E-04 Wnt, HH, 
MAPK, RAS, 
Apop 
PRKAR1B -0,6250 -0,7711 -0,4788 6,76E-05 2,59E-03 Apop 
PRKAR2A -0,5185 -0,6814 -0,3557 4,28E-04 1,07E-02 Apop 
PRKCG -0,9894 -1,3631 -0,6156 1,27E-03 2,39E-02 Wnt, MAPK, 
RAS 
PTCH1 -1,5642 -1,9771 -1,1513 1,46E-04 4,58E-03 HH 
PTTG2 -0,8886 -1,2041 -0,5730 8,88E-04 1,84E-02 CC 
RAD21 -0,5044 -0,5867 -0,4220 6,34E-06 3,73E-04 CC 
RBX1 -0,4333 -0,5762 -0,2904 5,75E-04 1,35E-02 Wnt, TGFB, CC 
RET -2,3199 -2,6334 -2,0064 1,77E-06 1,67E-04  
RFC3 -0,3268 -0,4318 -0,2218 4,91E-04 1,20E-02 DNARepair 
RFC4 -0,7051 -0,7921 -0,6180 9,57E-07 1,23E-04 DNARepair 
RPS27A -0,3945 -0,5260 -0,2630 6,11E-04 1,42E-02 DNARepair 
RXRG -0,8353 -1,1354 -0,5351 9,52E-04 1,95E-02 TXmisReg 
SETBP1 -0,6859 -0,9268 -0,4450 8,32E-04 1,75E-02  
SFN 0,7006 0,4280 0,9733 1,50E-03 2,72E-02 CC 
SHC1 0,6532 0,5177 0,7887 3,10E-05 1,34E-03 RAS 
SHC3 -0,9839 -1,2595 -0,7082 2,12E-04 6,36E-03 RAS 
SHC4 1,8139 1,0644 2,5633 2,10E-03 3,53E-02 RAS 
SKP1 0,3852 0,2758 0,4947 2,31E-04 6,80E-03 Wnt, TGFB, CC 
SKP2 -1,7866 -1,8553 -1,7180 2,92E-10 9,96E-07 CC 
SMARCA4 -0,5060 -0,6525 -0,3595 2,60E-04 7,52E-03  
SMC1A -0,6373 -0,8812 -0,3935 1,37E-03 2,54E-02 CC 
SMC3 -0,5299 -0,6568 -0,4029 7,91E-05 2,93E-03 CC 
SOS1 0,2741 0,1924 0,3558 3,12E-04 8,44E-03 MAPK, STAT, 
PI3K, RAS 
SOX9 -1,1863 -1,4995 -0,8731 1,46E-04 4,58E-03  
SPP1 3,6997 3,5318 3,8676 9,32E-10 1,59E-06 PI3K 
SPRY1 -1,9010 -2,1089 -1,6931 4,16E-07 8,06E-05 STAT 
SPRY2 -2,2614 -2,5893 -1,9336 2,84E-06 2,34E-04 STAT 
SPRY4 -1,7156 -1,8865 -1,5446 2,19E-07 6,23E-05 STAT 
STMN1 -0,8861 -1,0082 -0,7640 2,01E-06 1,86E-04 MAPK 
SUV39H2 -0,9394 -1,2014 -0,6774 2,06E-04 6,23E-03 ChromMod 
SYK -0,9234 -1,0631 -0,7838 3,78E-06 2,82E-04 PI3K 
TBL1XR1 -0,8011 -0,9949 -0,6073 8,41E-05 3,05E-03 Wnt 
TFDP1 -1,1946 -1,3691 -1,0202 2,98E-06 2,37E-04 TGFB, CC 
TGFB3 -2,9226 -3,0951 -2,7501 5,81E-09 4,96E-06 TGFB, MAPK, 
CC 
TGFBR2 -1,2031 -1,4429 -0,9633 2,39E-05 1,12E-03 TXmisReg, 
TGFB, MAPK 
THEM4 -1,0476 -1,3652 -0,7299 3,46E-04 9,15E-03 PI3K 
TIAM1 -0,8622 -1,2080 -0,5164 1,78E-03 3,07E-02 RAS 
TSPAN7 -0,5830 -0,8127 -0,3533 1,61E-03 2,86E-02 TXmisReg 
UBB 0,9993 0,7894 1,2092 3,37E-05 1,44E-03 DNARepair 
WEE1 -0,9888 -1,1700 -0,8076 1,37E-05 7,43E-04 CC 
WHSC1 -0,3151 -0,3970 -0,2332 1,33E-04 4,23E-03 TXmisReg 
WNT4 -1,9228 -2,3387 -1,5069 4,08E-05 1,70E-03 Wnt, HH 
XPA -0,6332 -0,8370 -0,4293 4,97E-04 1,20E-02 DNARepair 
ZBTB16 -1,2574 -1,5180 -0,9967 3,09E-05 1,34E-03 TXmisReg 
ZIC2 -1,6596 -2,2613 -1,0579 1,00E-03 2,00E-02 HH 
 
  
Suppl. table 3: differentially expressed genes after 24 h of 10 µM cisplatin plus 25 nM bortezomib 











limit p-value FDR pathway 
AKT1 -0,9807 -1,1656 -0,7958 1,66E-05 5,04E-04 MAPK, STAT, 
PI3K, RAS, 
Apop 
AKT2 -1,0736 -1,3087 -0,8385 4,42E-05 1,10E-03 MAPK, STAT, 
PI3K, RAS, 
Apop 
ALKBH2 0,6423 0,3618 0,9229 2,84E-03 3,68E-02 DNARepair 
ALKBH3 0,3576 0,2313 0,4839 8,60E-04 1,29E-02 DNARepair 
AMER1 -0,8477 -1,0989 -0,5964 3,01E-04 5,24E-03  
ARID1A -1,0200 -1,2201 -0,8199 2,15E-05 6,22E-04 ChromMod 
ARID1B -1,3941 -1,6962 -1,0920 4,13E-05 1,04E-03  
ARID2 -0,5133 -0,7274 -0,2991 2,22E-03 3,00E-02  
ARNT2 -1,7084 -1,8432 -1,5735 4,38E-08 1,07E-05 TXmisReg 
ATR -0,9776 -1,2591 -0,6961 2,51E-04 4,64E-03 CC 
ATRX -0,6803 -0,8495 -0,5112 1,00E-04 2,06E-03  
B2M -0,9631 -1,0896 -0,8365 1,46E-06 7,80E-05  
BAIAP3 -1,3572 -1,5237 -1,1907 9,14E-07 6,24E-05 TXmisReg 
BAX -0,7434 -0,8931 -0,5938 2,55E-05 7,01E-04 Apop 
BCL2 -1,3639 -1,6921 -1,0357 8,12E-05 1,73E-03 PI3K, Apop 
BCL2L1 -0,7880 -1,1406 -0,4354 3,23E-03 4,09E-02 TXmisReg, 
STAT, PI3K, 
RAS, Apop 
BCOR -1,2635 -1,4526 -1,0745 3,52E-06 1,56E-04  
BID 0,8028 0,5820 1,0236 1,89E-04 3,59E-03 Apop 
BMP7 -2,0759 -2,2576 -1,8942 8,97E-08 1,61E-05 TGFB 
BMPR1B -0,9132 -1,0299 -0,7965 1,21E-06 6,95E-05 TGFB 
BNIP3 0,9796 0,8659 1,0934 6,28E-07 4,87E-05 ChromMod 
BRCA2 -1,0197 -1,2040 -0,8354 1,25E-05 4,03E-04 DNARepair 
CACNA1C -1,7950 -2,3446 -1,2454 3,67E-04 6,26E-03 MAPK 
CACNA1D -1,3292 -1,7231 -0,9353 3,00E-04 5,24E-03 MAPK 
CACNA1H -1,5805 -1,7937 -1,3672 1,75E-06 8,77E-05 MAPK 
CACNA2D
1 
-2,0198 -2,1699 -1,8696 2,89E-08 8,97E-06 MAPK 
CACNA2D
2 
-1,3458 -1,6413 -1,0504 4,49E-05 1,10E-03 MAPK 
CACNB2 -1,0392 -1,3693 -0,7090 4,59E-04 7,53E-03 MAPK 
CAPN2 0,7980 0,7242 0,8718 1,31E-07 2,13E-05 Apop 
CASP3 -0,3290 -0,4731 -0,1849 2,88E-03 3,73E-02 MAPK, Apop 
CASP7 0,7982 0,6751 0,9213 4,32E-06 1,80E-04 Apop 
CASP8 0,6028 0,4154 0,7902 4,02E-04 6,78E-03 Apop 
CBLC -1,2965 -1,6672 -0,9259 2,41E-04 4,46E-03 STAT 
CCNA2 -1,1654 -1,3096 -1,0212 9,68E-07 6,35E-05 CC 
CCNB1 -0,8035 -0,9456 -0,6614 1,08E-05 3,65E-04 CC 
CCND1 -2,5093 -2,7701 -2,2485 2,93E-07 3,29E-05 Wnt, STAT, 
PI3K, CC 
CCNE1 -1,5851 -1,8093 -1,3609 2,41E-06 1,14E-04 PI3K, CC 
CDC14A -0,8155 -0,9869 -0,6441 3,38E-05 9,02E-04 CC 
CDC25B -1,1744 -1,2851 -1,0638 1,49E-07 2,31E-05 MAPK, CC 
CDC25C -0,8165 -1,0970 -0,5361 7,30E-04 1,13E-02 CC 
CDC7 -1,2397 -1,3810 -1,0984 5,52E-07 4,57E-05 CC 
CDH1 -0,7341 -0,8661 -0,6021 1,21E-05 4,00E-04  
CDK4 -0,7709 -0,9083 -0,6335 1,14E-05 3,81E-04 PI3K, CC 
CDK6 -1,2526 -1,4451 -1,0600 4,23E-06 1,80E-04 PI3K, CC 
CDKN1A 1,6324 1,4545 1,8102 4,05E-07 3,95E-05 TXmisReg, 
PI3K, CC 
CDKN2D -0,8283 -1,0928 -0,5639 4,72E-04 7,71E-03 CC 
CEBPA 3,5734 2,9255 4,2212 1,28E-05 4,07E-04 TXmisReg 
CHEK2 -0,6977 -0,8533 -0,5421 4,98E-05 1,21E-03 CC 
COL27A1 -1,5967 -1,8098 -1,3836 1,62E-06 8,40E-05 PI3K 
CREB3L1 -1,1121 -1,2613 -0,9629 1,68E-06 8,57E-05 PI3K 




CXXC4 -1,8885 -2,4801 -1,2969 4,21E-04 7,01E-03 Wnt 
CYLD 0,9466 0,7757 1,1175 1,24E-05 4,03E-04  
DDB2 -0,4997 -0,5664 -0,4330 1,63E-06 8,40E-05 DNARepair 
DDIT3 1,6567 1,4455 1,8679 1,19E-06 6,95E-05 TXmisReg, 
MAPK 
DKK1 -0,5927 -0,8636 -0,3217 3,62E-03 4,51E-02 Wnt 
DLL1 -2,1847 -2,4164 -1,9530 3,36E-07 3,59E-05 Notch 
DLL3 -2,1013 -2,2840 -1,9187 8,54E-08 1,61E-05 Notch 
DLL4 -2,0373 -2,2974 -1,7772 1,20E-06 6,95E-05 Notch 
DNMT1 -0,6796 -0,8158 -0,5433 2,48E-05 6,94E-04  
DNMT3A -0,6120 -0,7672 -0,4568 1,14E-04 2,28E-03  
DUSP4 -1,5784 -1,7400 -1,4169 2,64E-07 3,21E-05 MAPK 
DUSP6 -2,3266 -2,5771 -2,0761 3,74E-07 3,75E-05 TXmisReg, 
MAPK 
E2F1 -1,0131 -1,1381 -0,8880 9,54E-07 6,35E-05 CC 
E2F5 -2,0717 -2,2434 -1,9000 6,15E-08 1,31E-05 TGFB, CC 
EFNA3 0,9523 0,6642 1,2403 3,40E-04 5,87E-03 PI3K, RAS 
EFNA5 -1,9691 -2,2218 -1,7164 1,24E-06 6,95E-05 PI3K, RAS 
EGFR -1,2340 -1,4194 -1,0487 3,62E-06 1,57E-04 MAPK, PI3K, 
RAS 
EIF4EBP1 -0,6686 -0,8509 -0,4864 1,79E-04 3,40E-03 PI3K 
ENDOG -1,8226 -2,1377 -1,5075 9,31E-06 3,24E-04 Apop 
EPOR -1,3214 -1,6364 -1,0064 7,65E-05 1,69E-03 STAT, PI3K 
ERCC2 -0,9443 -1,1704 -0,7182 7,87E-05 1,69E-03 DNARepair 
ETS2 -1,6030 -1,7249 -1,4810 3,39E-08 9,64E-06 RAS 
ETV1 -2,2399 -2,3852 -2,0945 1,12E-08 6,40E-06 TXmisReg 
ETV4 -1,0200 -1,2276 -0,8123 2,74E-05 7,49E-04 TXmisReg 
FANCA -0,5632 -0,7062 -0,4202 1,14E-04 2,28E-03 DNARepair 
FANCC -1,0363 -1,2155 -0,8572 9,29E-06 3,24E-04 DNARepair 
FANCF -0,6172 -0,8835 -0,3509 2,66E-03 3,51E-02 DNARepair 
FAS 1,1879 0,6797 1,6961 2,54E-03 3,37E-02 MAPK, Apop 
FASLG -1,3073 -1,7741 -0,8406 9,16E-04 1,37E-02 MAPK, PI3K, 
RAS, Apop 
FBXW7 -0,9567 -1,2252 -0,6882 2,15E-04 4,03E-03  
FEN1 -0,5254 -0,7339 -0,3170 1,68E-03 2,33E-02 DNARepair 
FGF11 -0,4964 -0,6867 -0,3061 1,38E-03 1,95E-02 MAPK, PI3K, 
RAS 
FGF12 -0,9910 -1,1612 -0,8208 8,90E-06 3,20E-04 MAPK, PI3K, 
RAS 
FGF14 -2,3022 -2,3720 -2,2325 5,54E-11 9,46E-08 MAPK, PI3K, 
RAS 
FGF9 1,0798 0,8654 1,2943 2,33E-05 6,58E-04 MAPK, PI3K, 
RAS 
FGFR3 -0,4816 -0,6651 -0,2980 1,34E-03 1,90E-02 MAPK, PI3K, 
RAS 
FGFR4 -1,4136 -1,8260 -1,0011 2,73E-04 4,98E-03 MAPK, PI3K, 
RAS 
FLNA 0,9391 0,7989 1,0794 3,48E-06 1,56E-04 MAPK 
FOSL1 2,3621 2,0926 2,6317 5,57E-07 4,57E-05 Wnt 
FST 0,6942 0,4412 0,9473 1,03E-03 1,51E-02 TGFB 
FUT8 -1,7046 -2,0905 -1,3187 5,49E-05 1,31E-03 TXmisReg 
FZD10 -0,8359 -1,0958 -0,5759 4,03E-04 6,78E-03 Wnt 
GADD45A 0,4630 0,3713 0,5548 2,30E-05 6,53E-04 MAPK, CC 
GADD45B 1,1070 0,7811 1,4329 2,88E-04 5,15E-03 MAPK, CC 
GATA2 -1,0626 -1,5128 -0,6124 2,41E-03 3,21E-02  
GNAQ -0,7168 -0,8369 -0,5967 7,54E-06 2,92E-04  
GNAS -0,5071 -0,7262 -0,2879 2,68E-03 3,52E-02  
GNG12 -1,6518 -1,8106 -1,4930 1,71E-07 2,43E-05 MAPK, PI3K, 
RAS 
GNG4 -1,7010 -1,9997 -1,4023 1,03E-05 3,52E-04 PI3K, RAS 
GPC4 -1,1511 -1,4094 -0,8928 5,18E-05 1,24E-03 Wnt 
GRB2 0,4380 0,3302 0,5459 9,39E-05 1,95E-03 MAPK, STAT, 
PI3K, RAS 
GSK3B -0,4568 -0,5487 -0,3649 2,54E-05 7,01E-04 Wnt, HH, PI3K, 
CC 
H2AFX -0,5660 -0,8115 -0,3204 2,74E-03 3,58E-02 DNARepair 
H3F3A -1,4337 -1,6598 -1,2077 5,02E-06 2,04E-04 TXmisReg 
H3F3C -0,8531 -1,0289 -0,6774 2,96E-05 7,96E-04 TXmisReg 
HDAC1 -1,0497 -1,1860 -0,9133 1,35E-06 7,43E-05 Notch, 
ChromMod, 
TXmisReg, CC 
HDAC10 -1,2320 -1,5349 -0,9291 9,32E-05 1,95E-03 ChromMod 
HDAC11 -0,7660 -1,0401 -0,4918 9,29E-04 1,38E-02 ChromMod 
HDAC2 -0,5455 -0,7157 -0,3753 4,11E-04 6,88E-03 Notch, 
ChromMod, 
TXmisReg, CC 
HDAC4 -1,8441 -2,2662 -1,4219 5,90E-05 1,36E-03 ChromMod 
HELLS -0,5088 -0,7213 -0,2963 2,23E-03 3,01E-02 ChromMod 
HES1 -2,0736 -2,3692 -1,7780 2,54E-06 1,19E-04 Notch 
HHEX 1,0681 0,8962 1,2399 5,75E-06 2,28E-04 TXmisReg 
HIST1H3B -0,9909 -1,3935 -0,5883 1,91E-03 2,62E-02 TXmisReg 
HIST1H3G -1,2507 -1,5759 -0,9255 1,33E-04 2,59E-03 TXmisReg 
HIST1H3
H 
-0,8722 -1,2202 -0,5243 1,73E-03 2,39E-02 TXmisReg 
HMGA2 -3,6508 -3,9338 -3,3678 3,87E-08 1,01E-05 TXmisReg 
HNF1A -2,0197 -2,6791 -1,3602 5,41E-04 8,70E-03  
HOXA10 -1,1626 -1,4116 -0,9136 3,83E-05 9,74E-04 TXmisReg 
HRAS -1,1301 -1,3687 -0,8914 3,49E-05 9,22E-04 MAPK, PI3K, 
RAS 
HSP90B1 0,4408 0,3317 0,5499 9,71E-05 2,01E-03 PI3K 
HSPA1A 5,6833 4,9955 6,3710 8,32E-07 5,91E-05 MAPK 
HSPB1 2,0536 1,4847 2,6225 1,98E-04 3,73E-03 MAPK 
ID1 -3,5044 -3,8520 -3,1568 2,13E-07 2,79E-05 TGFB 
ID2 -2,8198 -3,0262 -2,6134 2,60E-08 8,86E-06 TXmisReg, 
TGFB 
ID4 -1,6000 -1,7943 -1,4057 8,53E-07 5,94E-05 TGFB 
IDH1 0,5947 0,4006 0,7887 5,39E-04 8,70E-03  
IDH2 -2,0894 -2,2681 -1,9108 7,63E-08 1,53E-05  
IGF1R -0,9114 -1,1200 -0,7028 5,89E-05 1,36E-03 TXmisReg, 
PI3K, RAS 
IGFBP3 0,6874 0,4623 0,9125 5,50E-04 8,81E-03 TXmisReg 
IKBKG 0,8559 0,6733 1,0384 3,72E-05 9,64E-04 MAPK, PI3K, 
RAS, Apop 
IL12A 1,8824 1,4835 2,2813 3,57E-05 9,37E-04 STAT 
IL12RB2 -0,8688 -1,0656 -0,6719 5,52E-05 1,31E-03 STAT 
IL1R2 -0,7917 -1,1083 -0,4752 1,75E-03 2,42E-02 TXmisReg, 
MAPK 
IL1RAP -1,2490 -1,6894 -0,8086 8,52E-04 1,29E-02 Apop 
IL20RA -0,8809 -1,2802 -0,4817 3,46E-03 4,33E-02 STAT 
IL6R 0,5510 0,3410 0,7611 1,34E-03 1,90E-02 STAT, PI3K 
IL8 1,3773 1,1717 1,5829 3,47E-06 1,56E-04 TXmisReg 
INHBB -2,1667 -2,3917 -1,9417 2,91E-07 3,29E-05 TGFB 
IRS1 -1,3503 -1,6022 -1,0984 1,54E-05 4,74E-04 PI3K 
ITGA3 -0,8730 -1,0175 -0,7285 6,95E-06 2,73E-04 PI3K 
ITGB8 -1,4632 -1,7963 -1,1300 5,69E-05 1,34E-03 PI3K 
JAG2 -1,5027 -1,7558 -1,2496 7,81E-06 2,96E-04 Notch 
JUN 0,9243 0,6197 1,2288 5,71E-04 9,10E-03 Wnt, MAPK 
KAT2B -1,5564 -1,9804 -1,1324 1,78E-04 3,40E-03 Notch 
KRAS 0,2385 0,1833 0,2936 6,28E-05 1,43E-03 MAPK, PI3K, 
RAS 
LAMA5 -1,0550 -1,4451 -0,6649 1,12E-03 1,63E-02 PI3K 
LAMB3 1,3296 1,1954 1,4639 2,40E-07 3,03E-05 PI3K 
LEPR -0,7308 -1,0580 -0,4037 3,24E-03 4,09E-02 STAT 
LFNG -3,4769 -3,7090 -3,2448 1,37E-08 6,67E-06 Notch 
LIF -1,5129 -1,8010 -1,2248 1,77E-05 5,25E-04 STAT 
LIFR 0,8740 0,5151 1,2329 2,03E-03 2,77E-02 STAT 
LIG4 -0,8951 -1,1213 -0,6690 1,11E-04 2,24E-03 DNARepair 
LTBP1 -1,7490 -2,0194 -1,4786 4,39E-06 1,81E-04 TGFB 
MAML2 -1,6772 -2,4193 -0,9351 3,05E-03 3,88E-02 Notch 
MAP2K1 0,5542 0,4831 0,6253 1,24E-06 6,95E-05 MAPK, PI3K, 
RAS 
MAP2K6 -1,3280 -1,4733 -1,1828 4,16E-07 3,95E-05 MAPK 
MAP3K14 1,1213 0,7765 1,4661 3,77E-04 6,39E-03 MAPK, Apop 
MAP3K5 -1,5052 -1,7896 -1,2207 1,68E-05 5,07E-04 MAPK 
MAPK12 -0,8680 -1,2328 -0,5033 2,30E-03 3,08E-02 MAPK 
MAPK3 -0,7089 -0,8787 -0,5392 7,87E-05 1,69E-03 TGFB, MAPK, 
PI3K, RAS 
MAPK8 -0,3540 -0,4161 -0,2918 1,03E-05 3,52E-04 Wnt, MAPK, 
RAS 
MAPK8IP1 -0,8032 -1,1566 -0,4498 2,96E-03 3,79E-02 MAPK 
MCM7 -0,6709 -0,8722 -0,4696 3,24E-04 5,62E-03 CC 
MDC1 -0,6025 -0,8654 -0,3396 2,83E-03 3,68E-02 DNARepair 
MECOM -1,8921 -2,1837 -1,6005 4,30E-06 1,80E-04 MAPK 
MEN1 0,2450 0,1370 0,3531 2,99E-03 3,82E-02 TXmisReg 
MET 1,0374 0,9349 1,1400 2,08E-07 2,79E-05 TXmisReg, 
PI3K, RAS 
MFNG -1,4404 -2,1135 -0,7672 4,07E-03 4,99E-02 Notch 
MLLT3 -1,2893 -1,3798 -1,1988 1,94E-08 7,37E-06 TXmisReg 
MSH2 -0,3622 -0,4689 -0,2554 2,91E-04 5,16E-03  
MTOR -0,8275 -1,1189 -0,5362 8,45E-04 1,29E-02 PI3K 
MYB -2,8357 -3,0301 -2,6412 1,65E-08 7,03E-06 PI3K 





MYD88 -0,9418 -1,2594 -0,6241 6,57E-04 1,03E-02 Apop 
NCOR1 -0,6424 -0,8089 -0,4760 1,30E-04 2,55E-03 TXmisReg 
NF1 -0,6167 -0,7958 -0,4377 2,64E-04 4,85E-03 MAPK, RAS 
NFKB1 -1,3163 -1,6308 -1,0017 7,77E-05 1,69E-03 TXmisReg, 
MAPK, PI3K, 
RAS, Apop 
NFKBIA -0,3354 -0,4712 -0,1996 1,88E-03 2,58E-02 Apop 
NKD1 -1,1863 -1,4075 -0,9650 1,54E-05 4,74E-04 Wnt 
NOTCH1 2,3801 1,6849 3,0754 2,75E-04 4,99E-03 Notch 
NOTCH3 1,0312 0,6653 1,3972 8,85E-04 1,32E-02 Notch 
NPM2 -1,2374 -1,6162 -0,8585 3,67E-04 6,26E-03 ChromMod 
NSD1 -0,9467 -1,2500 -0,6434 4,83E-04 7,84E-03 ChromMod 
NTHL1 -1,0870 -1,3504 -0,8236 8,49E-05 1,80E-03 DNARepair 
NUMBL 1,4168 1,1754 1,6582 8,44E-06 3,06E-04 Notch 
PAX5 -1,5857 -1,9540 -1,2174 6,48E-05 1,46E-03 TXmisReg 
PBRM1 -0,9680 -1,1472 -0,7889 1,46E-05 4,58E-04  
PBX1 -1,9491 -2,1730 -1,7251 5,83E-07 4,63E-05 TXmisReg 
PBX3 -1,3129 -1,4692 -1,1567 7,42E-07 5,39E-05 TXmisReg 
PDGFD -1,4726 -1,6302 -1,3151 3,57E-07 3,70E-05 PI3K, RAS 
PGF 2,8718 2,5310 3,2126 7,28E-07 5,39E-05 PI3K, RAS 
PHF6 -0,4473 -0,5745 -0,3201 2,33E-04 4,35E-03  
PIK3CB -1,2989 -1,5224 -1,0755 9,00E-06 3,20E-04 STAT, PI3K, 
RAS, Apop 
PIK3R1 -0,9450 -1,1311 -0,7589 2,21E-05 6,33E-04 STAT, PI3K, 
RAS, Apop 
PIK3R2 -1,2498 -1,7456 -0,7541 1,67E-03 2,33E-02 STAT, PI3K, 
RAS, Apop 
PLA2G4C 0,7713 0,4526 1,0900 2,10E-03 2,86E-02 MAPK, RAS 
PLCB1 -1,5653 -1,7435 -1,3872 5,46E-07 4,57E-05 Wnt 
PLD1 -0,6821 -0,9400 -0,4241 1,28E-03 1,83E-02 RAS 
POLB 0,6620 0,4044 0,9195 1,50E-03 2,12E-02 DNARepair 
POLD1 -1,5369 -1,9425 -1,1312 1,46E-04 2,83E-03 DNARepair 
POLD4 -0,7534 -0,8908 -0,6159 1,33E-05 4,21E-04 DNARepair 
POLE2 -0,6949 -1,0151 -0,3748 3,77E-03 4,66E-02 DNARepair 
POLR2D -0,6428 -0,7854 -0,5003 4,80E-05 1,17E-03 DNARepair 
POLR2H -1,0426 -1,2650 -0,8202 3,73E-05 9,64E-04 DNARepair 
PPARGC1
A 
-0,5283 -0,7555 -0,3010 2,62E-03 3,46E-02 ChromMod 
PPP2CB 0,5768 0,4294 0,7243 1,19E-04 2,36E-03 TGFB, PI3K 
PPP2R1A -0,6376 -0,8703 -0,4050 1,04E-03 1,52E-02 TGFB, PI3K 
PPP2R2C 1,0169 0,7608 1,2731 1,09E-04 2,21E-03 PI3K 
PPP3CA -1,0774 -1,2606 -0,8941 8,34E-06 3,06E-04 Wnt, MAPK, 
Apop 
PPP3CB -1,2543 -1,5493 -0,9593 7,02E-05 1,58E-03 Wnt, MAPK, 
Apop 
PPP3R1 -0,3243 -0,4733 -0,1753 3,71E-03 4,61E-02 Wnt, MAPK, 
Apop 
PRKACA -0,9486 -1,0570 -0,8402 5,61E-07 4,57E-05 Wnt, HH, 
MAPK, RAS, 
Apop 
PRKAR1B -1,6063 -1,7371 -1,4756 5,41E-08 1,23E-05 Apop 
PRKAR2A -0,7558 -0,9015 -0,6101 1,92E-05 5,63E-04 Apop 
PRKCA -2,0576 -2,6609 -1,4543 2,81E-04 5,05E-03 Wnt, MAPK, 
PI3K, RAS 
PRKCG -1,1403 -1,4746 -0,8060 2,81E-04 5,05E-03 Wnt, MAPK, 
RAS 
PRKDC -0,8910 -1,1298 -0,6522 1,61E-04 3,10E-03 DNARepair, CC 
PTCH1 -2,0426 -2,4119 -1,6733 1,25E-05 4,03E-04 HH 
PTPN11 -0,2938 -0,3806 -0,2071 2,93E-04 5,16E-03 STAT, RAS 
PTTG2 -1,3210 -1,6033 -1,0388 3,77E-05 9,66E-04 CC 
RAD21 -0,5331 -0,6068 -0,4595 2,05E-06 1,00E-04 CC 
RAD50 -0,9363 -1,1604 -0,7123 7,84E-05 1,69E-03 DNARepair 
RASGRF2 -1,1361 -1,5120 -0,7601 5,86E-04 9,26E-03 MAPK, RAS 
RBX1 -0,5826 -0,7104 -0,4547 4,48E-05 1,10E-03 Wnt, TGFB, CC 
RET -2,6902 -2,9706 -2,4099 2,99E-07 3,29E-05  
RFC4 -0,6918 -0,7697 -0,6139 5,08E-07 4,57E-05 DNARepair 
RPS27A -0,3558 -0,4734 -0,2382 5,82E-04 9,23E-03 DNARepair 
RRAS2 0,5257 0,2885 0,7630 3,38E-03 4,26E-02 MAPK, RAS 
RXRG -0,9097 -1,1782 -0,6412 2,93E-04 5,16E-03 TXmisReg 
SETBP1 -0,8834 -1,0988 -0,6679 8,85E-05 1,86E-03  
SFN 1,0323 0,7884 1,2761 7,22E-05 1,61E-03 CC 
SHC1 0,5619 0,4408 0,6831 4,00E-05 1,01E-03 RAS 
SHC2 -1,4755 -1,8117 -1,1393 5,72E-05 1,34E-03 RAS 
SHC3 -1,6395 -1,8861 -1,3930 3,65E-06 1,57E-04 RAS 
SHC4 1,7751 1,1048 2,4455 1,27E-03 1,82E-02 RAS 
SKP1 0,5025 0,4046 0,6004 2,05E-05 5,99E-04 Wnt, TGFB, CC 
SKP2 -2,1795 -2,2410 -2,1181 3,34E-11 9,46E-08 CC 
SMAD2 -0,5609 -0,7725 -0,3492 1,26E-03 1,82E-02 TGFB, CC 
SMAD3 -0,6981 -0,8310 -0,5653 1,76E-05 5,25E-04 Wnt, TGFB, CC 
SMARCA4 -0,9498 -1,0808 -0,8188 2,03E-06 1,00E-04  
SMARCB1 -1,1409 -1,5543 -0,7274 9,99E-04 1,48E-02  
SMC1A -1,0598 -1,2779 -0,8416 2,95E-05 7,96E-04 CC 
SMC3 -0,4930 -0,6066 -0,3794 6,14E-05 1,41E-03 CC 
SOCS1 0,9353 0,5641 1,3064 1,68E-03 2,33E-02 STAT 
SOS2 -0,4277 -0,5751 -0,2803 7,45E-04 1,14E-02 MAPK, STAT, 
PI3K, RAS 
SOX9 -1,1732 -1,4533 -0,8931 7,73E-05 1,69E-03  
SPP1 4,0253 3,8751 4,1755 2,37E-10 2,70E-07 PI3K 
SPRY1 -3,1193 -3,3052 -2,9333 6,24E-09 4,25E-06 STAT 
SPRY2 -2,5659 -2,8591 -2,2726 5,62E-07 4,57E-05 STAT 
SPRY4 -1,6887 -1,8416 -1,5358 1,13E-07 1,93E-05 STAT 
STAT3 -0,4100 -0,5904 -0,2297 2,95E-03 3,79E-02 STAT 
STMN1 -0,8760 -0,9852 -0,7668 1,02E-06 6,51E-05 MAPK 
SUV39H2 -0,6834 -0,9177 -0,4491 7,23E-04 1,13E-02 ChromMod 
SYK -1,0600 -1,1849 -0,9351 6,93E-07 5,26E-05 PI3K 
TBL1XR1 -1,3606 -1,5339 -1,1872 1,18E-06 6,95E-05 Wnt 
TCF3 -0,7300 -0,9163 -0,5436 1,19E-04 2,35E-03 TXmisReg 
TFDP1 -1,2495 -1,4055 -1,0935 1,03E-06 6,51E-05 TGFB, CC 
TGFB3 -3,3835 -3,5377 -3,2292 9,63E-10 8,21E-07 TGFB, MAPK, 
CC 
TGFBR2 -1,6402 -1,8547 -1,4257 1,41E-06 7,65E-05 TXmisReg, 
TGFB, MAPK 
THEM4 -0,9034 -1,1875 -0,6193 4,32E-04 7,15E-03 PI3K 
TIAM1 -2,1979 -2,5072 -1,8886 2,33E-06 1,12E-04 RAS 
TNFRSF1
0A 
0,9001 0,6167 1,1834 4,34E-04 7,16E-03 Apop 
TNFRSF1
0D 
1,1259 0,7283 1,5236 8,60E-04 1,29E-02 Apop 
TNFSF10 -0,5023 -0,7346 -0,2699 3,85E-03 4,75E-02 Apop 
TNR -2,8335 -3,1917 -2,4753 1,12E-06 6,95E-05 PI3K 
TSPAN7 -0,8158 -1,0212 -0,6103 1,09E-04 2,21E-03 TXmisReg 
UBB 1,1061 0,9183 1,2938 8,23E-06 3,05E-04 DNARepair 
VHL -0,6559 -0,8830 -0,4288 7,66E-04 1,17E-02  
WEE1 -0,9629 -1,1249 -0,8008 7,77E-06 2,96E-04 CC 
WHSC1 -0,5012 -0,5745 -0,4280 3,00E-06 1,38E-04 TXmisReg 
WNT3 1,0606 0,6961 1,4252 7,34E-04 1,13E-02 Wnt, HH 
WNT4 -2,1991 -2,5711 -1,8271 8,04E-06 3,01E-04 Wnt, HH 
XPA -0,5015 -0,6839 -0,3192 1,02E-03 1,50E-02 DNARepair 
XRCC4 -0,6974 -0,9286 -0,4663 5,91E-04 9,29E-03 DNARepair 
ZBTB16 -2,4255 -2,6587 -2,1924 1,71E-07 2,43E-05 TXmisReg 
ZIC2 -1,2859 -1,8241 -0,7477 2,25E-03 3,03E-02 HH 
 
  
Suppl. table 4: differentially expressed genes after knockdown of FOXM1 in BON cells incl. pathway 











limit p-value FDR pathway 
AKT1 -0,1870 -0,2257 -0,1483 3,06E-05 2,75E-03 MAPK, STAT, 
PI3K, RAS, 
Apop 
ARID2 -0,4605 -0,6113 -0,3097 5,51E-04 2,17E-02   
ASXL1 -0,3863 -0,5145 -0,2581 5,95E-04 2,29E-02   
ATR 0,5032 0,3349 0,6715 6,24E-04 2,32E-02 CC 
AXIN1 -0,2037 -0,2761 -0,1313 8,93E-04 2,89E-02 Wnt 
B2M 1,0525 0,9082 1,1967 1,94E-06 4,84E-04   
BCL2 -0,6372 -0,7748 -0,4997 4,02E-05 3,42E-03 PI3K, Apop 
BMP4 0,5543 0,4288 0,6798 5,49E-05 4,28E-03 HH, TGFB 
BMPR1B 0,3593 0,2907 0,4279 1,80E-05 2,01E-03 TGFB 
CACNA1D -0,6287 -0,8218 -0,4357 3,73E-04 1,61E-02 MAPK 
CACNA2D1 0,3568 0,2325 0,4811 7,94E-04 2,62E-02 MAPK 
CASP7 0,7744 0,6268 0,9220 1,78E-05 2,01E-03 Apop 
CASP8 0,5016 0,3878 0,6154 5,56E-05 4,28E-03 Apop 
CCNA2 -0,5611 -0,6707 -0,4515 2,09E-05 2,12E-03 CC 
CCNB1 -0,7504 -0,8912 -0,6096 1,60E-05 1,99E-03 CC 
CCND1 0,3372 0,2691 0,4053 2,61E-05 2,56E-03 Wnt, STAT, 
PI3K, CC 
CCND3 -0,1519 -0,1993 -0,1046 4,07E-04 1,71E-02 Wnt, STAT, 
PI3K, CC 
CCNE1 -0,8845 -0,9924 -0,7765 8,83E-07 2,60E-04 PI3K, CC 
CCNE2 -0,1980 -0,2730 -0,1231 1,28E-03 3,70E-02 PI3K, CC 
CDC25C -0,5600 -0,7595 -0,3605 9,05E-04 2,90E-02 CC 
CDH1 -0,4856 -0,6326 -0,3387 3,41E-04 1,54E-02   
CDK6 -0,3873 -0,4845 -0,2900 1,07E-04 6,53E-03 PI3K, CC 
CDKN1A -0,5330 -0,7341 -0,3319 1,26E-03 3,67E-02 TXmisReg, 
PI3K, CC 
CDKN2C -0,2735 -0,3818 -0,1651 1,66E-03 4,50E-02 TXmisReg, CC 
CREB3L1 0,4262 0,3610 0,4915 4,12E-06 7,40E-04 PI3K 
CXXC4 -1,2706 -1,6266 -0,9145 2,13E-04 1,07E-02 Wnt 
DDIT4 0,5235 0,3381 0,7088 8,74E-04 2,85E-02 PI3K 
DKK1 0,9978 0,7670 1,2286 6,30E-05 4,53E-03 Wnt 
DKK4 1,4017 0,8628 1,9407 1,40E-03 3,91E-02 Wnt 
DLL1 -0,4583 -0,6042 -0,3124 4,65E-04 1,88E-02 Notch 
DNMT1 0,1614 0,1076 0,2151 6,09E-04 2,32E-02   
DNMT3A -0,2628 -0,3593 -0,1664 1,07E-03 3,22E-02   
DUSP4 0,6031 0,5377 0,6684 3,91E-07 1,58E-04 MAPK 
DUSP5 0,9524 0,8758 1,0289 4,97E-08 5,35E-05 MAPK 
EPHA2 1,0411 0,9433 1,1389 1,46E-07 9,44E-05 PI3K, RAS 
ERBB2 0,9267 0,5891 1,2644 1,03E-03 3,11E-02   
ETS2 -0,3286 -0,4055 -0,2517 6,79E-05 4,74E-03 RAS 
FGF12 -0,5017 -0,6490 -0,3545 2,83E-04 1,32E-02 MAPK, PI3K, 
RAS 
FGFR1 0,3585 0,2628 0,4542 1,57E-04 8,69E-03 MAPK, PI3K, 
RAS 
FLNA 0,4967 0,4138 0,5796 7,35E-06 1,08E-03 MAPK 
FOSL1 0,8222 0,6541 0,9903 2,82E-05 2,68E-03 Wnt 
GADD45B 0,6718 0,4473 0,8963 6,21E-04 2,32E-02 MAPK, CC 
GADD45G -0,8258 -1,0759 -0,5756 3,44E-04 1,54E-02 MAPK, CC 
GNA11 0,2854 0,2141 0,3567 1,03E-04 6,53E-03   
GNAS -0,2327 -0,3162 -0,1492 9,46E-04 2,97E-02   
GNG4 -0,2752 -0,3552 -0,1952 2,67E-04 1,27E-02 PI3K, RAS 
H3F3A -0,3834 -0,5307 -0,2361 1,40E-03 3,91E-02 TXmisReg 
H3F3C 0,2007 0,1576 0,2437 3,87E-05 3,39E-03 TXmisReg 
HDAC2 -0,3492 -0,4742 -0,2242 9,31E-04 2,95E-02 Notch, 
ChromMod, 
TXmisReg, CC 
HIST1H3B -0,8900 -1,0473 -0,7328 1,07E-05 1,45E-03 TXmisReg 
HIST1H3G -0,6325 -0,8322 -0,4328 4,42E-04 1,81E-02 TXmisReg 
HOXA10 0,7626 0,5902 0,9351 5,44E-05 4,28E-03 TXmisReg 
HSPA1A 0,4677 0,3256 0,6099 3,51E-04 1,55E-02 MAPK 
HSPB1 0,3995 0,2651 0,5339 6,46E-04 2,34E-02 MAPK 
ID2 -0,4263 -0,5814 -0,2712 1,02E-03 3,11E-02 TXmisReg, 
TGFB 
IL6R 0,3747 0,2548 0,4946 4,80E-04 1,91E-02 STAT, PI3K 
IL8 1,3519 1,1337 1,5700 5,86E-06 9,10E-04 TXmisReg 
IRS1 0,7333 0,4522 1,0144 1,38E-03 3,91E-02 PI3K 
ITGA2 0,8082 0,6187 0,9977 6,88E-05 4,74E-03 PI3K 
ITGA3 0,5313 0,3877 0,6748 1,69E-04 8,96E-03 PI3K 
ITGA6 0,5878 0,4761 0,6994 1,74E-05 2,01E-03 PI3K 
ITGB8 0,6457 0,4060 0,8854 1,15E-03 3,40E-02 PI3K 
JAG1 0,4517 0,3417 0,5616 8,76E-05 5,78E-03 Notch 
JAK1 0,4505 0,3478 0,5533 5,74E-05 4,32E-03 STAT, PI3K 
JAK2 0,6858 0,4488 0,9229 7,58E-04 2,55E-02 STAT, PI3K 
KITLG 0,2411 0,1594 0,3227 6,72E-04 2,36E-02 PI3K, RAS 
KLF4 0,7538 0,5523 0,9554 1,59E-04 8,69E-03   
LAMA3 1,5313 1,3045 1,7581 3,29E-06 6,64E-04 PI3K 
LAMC2 1,0066 0,8837 1,1294 8,83E-07 2,60E-04 PI3K 
LIF 1,5118 1,2166 1,8069 2,08E-05 2,12E-03 STAT 
LTBP1 0,8023 0,5500 1,0547 4,32E-04 1,79E-02 TGFB 
MAP2K6 1,0272 0,9229 1,1316 2,50E-07 1,29E-04 MAPK 
MAP3K5 0,4087 0,2614 0,5560 9,68E-04 3,00E-02 MAPK 
MET 0,5314 0,3844 0,6784 1,96E-04 1,01E-02 TXmisReg, 
PI3K, RAS 
MLLT3 0,8907 0,7468 1,0346 5,91E-06 9,10E-04 TXmisReg 





MYD88 0,8471 0,7721 0,9221 9,67E-08 7,82E-05 Apop 
NBN 0,5734 0,4203 0,7265 1,57E-04 8,69E-03 DNARepair 
NFKBIA 0,7915 0,5254 1,0577 6,44E-04 2,34E-02 Apop 
NFKBIZ 0,6622 0,4377 0,8867 6,76E-04 2,36E-02 TXmisReg 
NR4A3 0,8684 0,5222 1,2145 1,72E-03 4,59E-02 TXmisReg 
PLA1A 1,4512 0,9736 1,9288 5,67E-04 2,21E-02 RAS 
PLAU 1,8791 1,6161 2,1422 2,24E-06 5,16E-04 TXmisReg 
PLD1 0,6417 0,4231 0,8603 6,96E-04 2,39E-02 RAS 
PML 1,6182 1,5126 1,7239 1,17E-08 1,90E-05 TXmisReg 
POLD4 0,4420 0,3255 0,5584 1,45E-04 8,51E-03 DNARepair 
POLR2D -0,3441 -0,4291 -0,2591 9,60E-05 6,21E-03 DNARepair 
PRKAR2A -0,5341 -0,6746 -0,3936 1,43E-04 8,51E-03 Apop 
PTEN 0,1796 0,1237 0,2355 4,05E-04 1,71E-02 PI3K 
PTPN11 -0,4218 -0,5278 -0,3158 1,07E-04 6,53E-03 STAT, RAS 
PTTG2 -0,4419 -0,5672 -0,3165 2,30E-04 1,14E-02 CC 
RAD21 -0,3560 -0,4512 -0,2608 1,58E-04 8,69E-03 CC 
RASGRP1 0,6785 0,5173 0,8397 7,47E-05 5,03E-03 MAPK, RAS 
RET -0,8115 -1,1219 -0,5010 1,37E-03 3,91E-02   
RPS27A -0,2825 -0,3809 -0,1841 7,92E-04 2,62E-02 DNARepair 
RXRG 1,2438 1,0043 1,4834 1,91E-05 2,05E-03 TXmisReg 
SGK2 -0,3772 -0,5250 -0,2295 1,56E-03 4,27E-02 PI3K 
SHC1 0,2436 0,1689 0,3182 3,68E-04 1,61E-02 RAS 
SHC3 -1,0308 -1,4028 -0,6589 9,75E-04 3,00E-02 RAS 
SHC4 2,0702 1,7589 2,3816 3,65E-06 6,94E-04 RAS 
SKP2 0,3097 0,2264 0,3930 1,65E-04 8,87E-03 CC 
SOCS1 1,2631 1,0375 1,4887 1,16E-05 1,49E-03 STAT 
SOCS3 0,6208 0,4117 0,8299 6,50E-04 2,34E-02 STAT 
SOS1 -0,4488 -0,6010 -0,2966 6,78E-04 2,36E-02 MAPK, STAT, 
PI3K, RAS 
SPP1 2,1080 1,7756 2,4404 5,02E-06 8,54E-04 PI3K 
STAT1 4,2428 4,0937 4,3918 1,56E-10 5,04E-07 STAT 
SYK -0,1772 -0,2284 -0,1259 2,59E-04 1,25E-02 PI3K 
TBL1XR1 -0,2651 -0,3642 -0,1660 1,19E-03 3,51E-02 Wnt 
TGFB1 0,4950 0,3931 0,5969 2,95E-05 2,73E-03 TGFB, MAPK, 
CC 
TGFBR2 0,7392 0,6379 0,8405 1,94E-06 4,84E-04 TXmisReg, 
TGFB, MAPK 
THBS1 0,8960 0,7693 1,0226 2,40E-06 5,16E-04 TGFB, PI3K 
TLX1 0,8955 0,5866 1,2044 7,50E-04 2,55E-02 TXmisReg 
TNC 0,5513 0,3990 0,7037 1,95E-04 1,01E-02 PI3K 
TNFAIP3 1,4017 0,8458 1,9576 1,67E-03 4,50E-02   
TNFRSF10B 0,8766 0,6836 1,0696 4,58E-05 3,80E-03 Apop 
TNFRSF10D -0,8258 -0,9705 -0,6812 1,02E-05 1,43E-03 Apop 
TNFSF10 1,9171 1,7193 2,1149 2,79E-07 1,29E-04 Apop 




WEE1 0,3231 0,1986 0,4475 1,42E-03 3,92E-02 CC 
WHSC1 -0,1818 -0,2341 -0,1295 2,51E-04 1,23E-02 TXmisReg 




SUPPLEMENTARY MATERIAL & METHODS: 
 
List of antibodies used in the study 
Antigen (Order Number) obtained from Dilution 
(method) 
53BP1 (NB100-304)  Novus bio 1:3000 IHC 
Akt (# 4685) Cell Signaling 1:1000 WB 
ATM (#2873) Cell Signaling 1:1000 WB 
Aurora A (ab1287) Abcam 1:1000 WB 
BAX (5023) Cell Signaling 1:1000 WB 
beta-Tubulin (T5201) Sigma Aldrich 1:1000 WB 
BID (#2002) Cell Signaling 1:1000 WB 
BRCA2 (sc-8326) Santa Cruz 1:200 WB 
Caspase 6 (# 9762) Cell Signaling 1:1000 WB 
Caspase 8 (# 9746) Cell Signaling 1:1000 WB 
Chromogranin A (10702) Progen 1:50 WB 
CK2 (#2656) Cell Signaling 1:1000 WB 
cleaved PARP (# 5625) Cell Signaling 1:1000 WB 
Cyclin B1 (#4138) Cell Signaling 1:1000 WB 
DDB2 (sc-25368) Santa Cruz 1:1000 WB 
ERCC1 (#3885) Cell Signaling 1:1000 WB 
FADD (556402) BD Biosciences 1:1000 WB 
FANCA (#14657) Cell Signaling 1:1000 WB 
FANCC (Sc-28216) Santa Cruz 1:100 WB 
FEN1 (sc-28355) Santa Cruz Biotech 1:200 WB 
FOXM1 (sc-502) Santa Cruz Biotech 1:500 WB 
GAPDH (GTX627408) GeneTex 1:1000 WB 
HIF1-alpha (10006421) Cayman Chemical 1:50 IHC 
Ki-67 (clone SolA15) eBioscience 1:10000 IHC 
MDM2 (SC-965) Santa Cruz Biotech 1:500 WB 
p(Ser20)-p53 (#9287) Cell Signaling 1:200 WB 
p21 (sc-397) Santa Cruz Biotech 1:500 WB 
p27 (# 2552) Cell Signaling 1:1000 WB 
p53 (#2527) Cell Signaling 1:1000 WB 
p70S6 Kinase (# 2708) Cell Signaling 1:1000 WB 
pan-actin (#4968) Cell Signaling 1:1000 WB 
Phospho-AKT (Ser473) XP® (# 4060) Cell Signaling 1:1000 WB 
Phospho-AKT (Thr308) (# 2965) Cell Signaling 1:1000 WB 
Phospho-FOXO1 (Thr24)/FOXO3a (Thr32) (# 9464) Cell Signaling 1:1000 WB 
Phospho-histone H2AX (# 9718) Cell Signaling 1:1000 WB 
Phospho-histone H3 (Ser10) XP® (# 3377) Cell Signaling 1:1600 FACS 
Phospho-p44/42 ERK1/2 (Thr202/Tyr204) (# 4370) Cell Signaling 1:1000 WB 
Phospho-p53 (Ser20)  (# 9287) Cell Signaling 1:1000 WB 
Phospho-p70 S6 Kinase (Thr389) (# 9234) Cell Signaling 1:1000 WB 
Phospho-Rb (Ser780) (# 9307) Cell Signaling 1:1000 WB 
RAD51 (sc-8349) Santa Cruz Biotech 1:200 WB 
Rb (sc-50) Santa Cruz Biotech 1:200 WB 
RCF4 (sc-20996) Santa Cruz Biotech 1:200 WB 
RPA 70 (2267 Cell Signaling 1:1000 WB 
Rpb1 CTD (#2629) Cell Signaling 1:1000 WB 
SKP2 (# 2652) Cell Signaling 1:1000 WB 
SSTR2 (Sc-25676) Santa Cruz Biotech 1:50 IF 
TRADD (610573) BD Biosciences 1:1000 WB 
Vinculin (# 4650) Cell Signaling 1:1000 WB 
XPA (#14607) Cell Signaling 1:1000 WB 
XPD (#11963) Cell Signaling 1:1000 WB 
β-tubulin (T5201) Sigma Aldrich 1:1000 WB 
Abbreviations: FACS: Fluorescence-activated cell sorting, IF: Immune fluorescence, IHC: 
Immunohistochemistry, WB: Western Blot 
 
 
PET/MR imaging of mouse xenografts: 
Anatomic tumor MRI scans in axial direction were acquired using a high-resolution T2-weighted 2D 
fast spin echo sequence (T2 FSE 2D) with the following parameters:, TR = 8700 ms; TE = 103 ms; slice 
thickness/gap = 1.1 mm/ 0.1 mm; matrix = 256 x 256 mm; external averages = 5 and number of 
excitations = 2.  
To monitor glucose consumption of tumors post therapy, FDG-F18-PET imaging was performed for 30 
min starting approx. 45 min post intravenous injection of 0.15 mL of FDG-F18 into mouse tail vein, 
corresponding to approximately 15 MBq. PET images were reconstructed as follows: (iterative image 
reconstruction, [ordered subset expectation maximization]; iterations, 8; subsets, 6; voxel size, 
500 × 500 × 600 μm3). Acquisition protocols included a mouse whole body material map for attenuation 
and scatter correction during PET reconstruction. Prior to imaging, the PET/MRI system was calibrated 
for FDG so that local tissue concentrations in the tumor could be measured quantitatively in kBq/ml 
tissue. 
 
MR imaging of in ovo models: 
Tumor volume was determined by MR imaging prior to and after 7 days of treatment using a dedicated 
small animal 1 Tesla nanoScan PET/MRI (Mediso, Hungary) and a rat body coil.  
First, a short localizer scan was performed to ensure the right positioning of the egg within the coil.  
To monitor tumor plaque morphology and calculate the exact tumor volume, a T1 3D gradient echo 
(GRE) sequence was used: TR = 50 ms; TE = 2.7 ms; flip angle = 40°; slice thickness/ gap = 0.5 mm/ 
0 mm; matrix = 160 x 160 mm and number of excitations = 2 and a high resolution 2D T2-w turbo-spin 
echo sequence (T2-TSE) was established using the following parameters: 8885/100ms (TR/TE), FOV 
74 mm, matrix = 252, slice thickness = 500 µm, gap 100 µm, 4 no of average, resulting voxel size = 
117x117x500 µm3. The number of axial orientated slices was adjusted to cover the whole tumor.  
MR images were analyzed using the interviewFUSION software (Mediso, version 3.01.004.000). To 
determine total tumor volume, a volume-of-interest (VOI) was manually contoured, based on the T1w 
and T2w MR images. 
 
In ovo SPECT/CT imaging and analyses: 
In ovo SPECT/CT measurements were performed on a nanoSPECT/CTplus (Bioscan/Mediso) using rat 
apertures. Lu-177-DOTATOC was injected intravenously into CAM vasculature (0.05 ml; 20 MBq/egg) 
and eggs were scanned 3h post injection to ensure tracer accumulation in the tumor plaque. Eggs were 
maintained at 37 ºC using a heated bed. For anatomical definition, a CT-scan was performed at 45 kVp, 
64 mAs, 1000 ms exposure time and 360° rotation in 1° steps; image reconstruction: 150 µm cubic 
voxels, filtered backprojection and a Butterworth filter. Static SPECT imaging of the egg was performed 
(45 sec/projection, 40 min scan), reconstructed (‘Hi SPECT’, Bioscan) and analyzed (In Vivo Scope). 
The injected dose of radionuclide per egg (whole object activity) was determined by measuring the total 
activity in the syringe prior to and after injection, and all values corrected for radioactive decay. The 
tumor plaque activity was identified from fused SPECT/CT images by volume of interest analysis. 
  
 
